Search research articles
Contact Us
Filters
Showing results (231-240 of 329) with videos related to
Page
of 33
Sort By:
Open Forum Infectious Diseases
|
August 5, 2024
Similar Viral and Immune Characteristics of Kaposi Sarcoma in ART-treated People Living With HIV and Older Patients With Classic Kaposi Sarcoma
Léna Royston, Aude Jary, Carolina A Berini, et al.
The Journal of Antimicrobial Chemotherapy
|
September 24, 2015
Virological factors associated with outcome of dual maraviroc/raltegravir therapy (ANRS-157 trial)
Cathia Soulié, Lambert Assoumou, Mélanie Darty, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
July 28, 2020
Evolution of viral quasispecies during SARS-CoV-2 infection
Aude Jary, Valentin Leducq, Isabelle Malet, et al.
Antiviral Research
|
December 6, 2011
E17A mutation in HIV-1 Vpr confers resistance to didanosine in association with thymidine analog mutations
Slim Fourati, Isabelle Malet, Carolin A Guenzel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 29, 2021
Neutralization Heterogeneity of UK and South African Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants in BNT162b2-Vaccinated or Convalescent Coronavirus Disease 2019 (COVID-19) Healthcare Workers
Stéphane Marot, Isabelle Malet, Valentin Leducq, et al.
Plos One
|
August 1, 2012
Similar evolution of cellular HIV-1 DNA level in darunavir/ritonavir monotherapy versus triple therapy in MONOI-ANRS136 trial over 96 weeks
Sidonie Lambert-Niclot, Philippe Flandre, Marc-Antoine Valantin, et al.
The Journal of Antimicrobial Chemotherapy
|
January 29, 2019
Anti-gp41 antibody levels reflect HIV viral suppression and cellular reservoir in long-term antiretroviral-treated trial participants
Héloïse M Delagreverie, Maxime Grude, Sidonie Lambert-Niclot, et al.
Nature Communications
|
February 9, 2021
Rapid decline of neutralizing antibodies against SARS-CoV-2 among infected healthcare workers
Stéphane Marot, Isabelle Malet, Valentin Leducq, et al.
The Lancet. HIV
|
October 2, 2015
Effect of therapeutic intensification followed by HIV DNA prime and rAd5 boost vaccination on HIV-specific immunity and HIV reservoir (EraMune 02): a multicentre randomised clinical trial
Chad J Achenbach, Lambert Assoumou, Steven G Deeks, et al.
Frontiers in Veterinary Science
|
November 14, 2025
SARS-CoV-2 infection and exposure in cats and dogs in Romania
Andreea Paula Cozma, Mihaela Anca Dascalu, Ioana Buzdugan, et al.
Page
of 33
Search research articles
Search
Showing results (231-240 of 329) with videos related to
Sort By:
Page
of 33
Open Forum Infectious Diseases
|
August 5, 2024
Similar Viral and Immune Characteristics of Kaposi Sarcoma in ART-treated People Living With HIV and Older Patients With Classic Kaposi Sarcoma
Léna Royston, Aude Jary, Carolina A Berini, et al.
The Journal of Antimicrobial Chemotherapy
|
September 24, 2015
Virological factors associated with outcome of dual maraviroc/raltegravir therapy (ANRS-157 trial)
Cathia Soulié, Lambert Assoumou, Mélanie Darty, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
July 28, 2020
Evolution of viral quasispecies during SARS-CoV-2 infection
Aude Jary, Valentin Leducq, Isabelle Malet, et al.
Antiviral Research
|
December 6, 2011
E17A mutation in HIV-1 Vpr confers resistance to didanosine in association with thymidine analog mutations
Slim Fourati, Isabelle Malet, Carolin A Guenzel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 29, 2021
Neutralization Heterogeneity of UK and South African Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants in BNT162b2-Vaccinated or Convalescent Coronavirus Disease 2019 (COVID-19) Healthcare Workers
Stéphane Marot, Isabelle Malet, Valentin Leducq, et al.
Plos One
|
August 1, 2012
Similar evolution of cellular HIV-1 DNA level in darunavir/ritonavir monotherapy versus triple therapy in MONOI-ANRS136 trial over 96 weeks
Sidonie Lambert-Niclot, Philippe Flandre, Marc-Antoine Valantin, et al.
The Journal of Antimicrobial Chemotherapy
|
January 29, 2019
Anti-gp41 antibody levels reflect HIV viral suppression and cellular reservoir in long-term antiretroviral-treated trial participants
Héloïse M Delagreverie, Maxime Grude, Sidonie Lambert-Niclot, et al.
Nature Communications
|
February 9, 2021
Rapid decline of neutralizing antibodies against SARS-CoV-2 among infected healthcare workers
Stéphane Marot, Isabelle Malet, Valentin Leducq, et al.
The Lancet. HIV
|
October 2, 2015
Effect of therapeutic intensification followed by HIV DNA prime and rAd5 boost vaccination on HIV-specific immunity and HIV reservoir (EraMune 02): a multicentre randomised clinical trial
Chad J Achenbach, Lambert Assoumou, Steven G Deeks, et al.
Frontiers in Veterinary Science
|
November 14, 2025
SARS-CoV-2 infection and exposure in cats and dogs in Romania
Andreea Paula Cozma, Mihaela Anca Dascalu, Ioana Buzdugan, et al.
Page
of 33